Iterum Therapeutics's total assets for Q4 2024 were $44.59M, an increase of 180.05% from the previous quarter. ITRM total liabilities were $48.68M for the fiscal quarter, a 77.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.